Protagonist Therapeutics saw the highest growth of 99% in patent filings in October and 299% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Protagonist Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Protagonist Therapeutics has been focused on protecting inventions in United States(US) with four publications in Q4 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 12% filings and 60% grants. The Australia(AU), World Intellectual Property Organization(WIPO), United States(US), and Argentina(AR) patent Office are among the top ten patent offices where Protagonist Therapeutics is filings its patents. Among the top granted patent authorities, Protagonist Therapeutics has 60% of its grants in United States(US) and 20% in Canada(CA).

Sanofi and F. Hoffmann-La Roche could be the strongest competitors for Protagonist Therapeutics

Patents related to rare diseases lead Protagonist Therapeutics's portfolio

Protagonist Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q4 2023.

Ileitis related patents lead Protagonist Therapeutics portfolio followed by inflammatory bowel disease, and hemochromatosis

Protagonist Therapeutics has highest number of patents in ileitis followed by inflammatory bowel disease, hemochromatosis, ulcerative colitis, and sinusitis. For ileitis, nearly 12% of patents were filed and 4% of patents were granted in Q4 2023.

For comprehensive analysis of Protagonist Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.